Clinical Trials
6 trialsNCT06494540 2026-05-22
NAUTIC
AstraZeneca
Recruiting
NCT05868629 2026-04-01
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Novartis
Recruiting
NCT04480814 2025-12-30
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
Pharmassist Ltd
Completed
NCT05982886 2023-08-09
Biomarker Testing and Treatment Patterns Among Patients With PIK3CA Mutation in Advanced Breast Cancer
Novartis
Completed
NCT04285723 2023-02-09
EPIK-P1
Novartis
Completed
NCT04425200 2021-12-07
ZENSHIN
AstraZeneca
Completed